Cord blood therapy offered for long COVID sufferers
Disease control
AVAILABLE
This expanded access program offers an infusion of umbilical cord blood cells (REGENECYTE) to adults with long COVID who are not eligible for other trials. The goal is to see if it can ease persistent symptoms like fatigue. Participants must have a recent negative COVID-19 test a…
Sponsor: StemCyte, Inc. • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC